Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

NF-kappa-B inhibitor-like protein 1 (Inhibitor of kappa B-like protein) (I-kappa-B-like protein) (IkappaBL) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1)

 IKBL1_HUMAN             Reviewed;         381 AA.
Q9UBC1; A6NL91; B4DUW1; Q14625; Q5HYU4; Q5RJ72; Q5ST96; Q5STV4;
Q5STV5; Q9UBX4;
01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
01-MAY-2000, sequence version 1.
23-MAY-2018, entry version 151.
RecName: Full=NF-kappa-B inhibitor-like protein 1;
AltName: Full=Inhibitor of kappa B-like protein;
Short=I-kappa-B-like protein;
Short=IkappaBL;
AltName: Full=Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1;
Name=NFKBIL1; Synonyms=IKBL;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
TISSUE=Premonocytic leukemia;
PubMed=8081366; DOI=10.1093/hmg/3.5.793;
Albertella M.R., Campbell D.R.;
"Characterization of a novel gene in the human major
histocompatibility complex that encodes a potential new member of the
I kappa B family of proteins.";
Hum. Mol. Genet. 3:793-799(1994).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=9480751; DOI=10.1006/geno.1997.5114;
Shiina T., Tamiya G., Oka A., Yamagata T., Yamagata N., Kikkawa E.,
Goto K., Mizuki N., Watanabe K., Fukuzumi Y., Taguchi S., Sugawara C.,
Ono A., Chen L., Yamazaki M., Tashiro H., Ando A., Ikemura T.,
Kimura M., Inoko H.;
"Nucleotide sequencing analysis of the 146-kilobase segment around the
IkBL and MICA genes at the centromeric end of the HLA class I
region.";
Genomics 47:372-382(1998).
[3]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-224.
PubMed=10369924; DOI=10.1007/s002510050662;
Allcock R.J.N., Christiansen F.T., Price P.;
"The central MHC gene IKBL carries a structural polymorphism that is
associated with HLA-A3,B7,DR15.";
Immunogenetics 49:660-665(1999).
[4]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=10202016;
Neville M.J., Campbell R.D.;
"A new member of the Ig superfamily and a V-ATPase G subunit are among
the predicted products of novel genes close to the TNF locus in the
human MHC.";
J. Immunol. 162:4745-4754(1999).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Shiina S., Tamiya G., Oka A., Inoko H.;
"Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Shiina T., Ota M., Katsuyama Y., Hashimoto N., Inoko H.;
"Genome diversity in HLA: a new strategy for detection of genetic
polymorphisms in expressed genes within the HLA class III and class I
regions.";
Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
[8]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-224.
PubMed=14574404; DOI=10.1038/nature02055;
Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
"The DNA sequence and analysis of human chromosome 6.";
Nature 425:805-811(2003).
[9]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[10]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
ARG-224.
TISSUE=Brain;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[11]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-150, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
Greff Z., Keri G., Stemmann O., Mann M.;
"Kinase-selective enrichment enables quantitative phosphoproteomics of
the kinome across the cell cycle.";
Mol. Cell 31:438-448(2008).
[12]
FUNCTION, INTERACTION WITH CACTIN, AND SUBCELLULAR LOCATION.
PubMed=20829348; DOI=10.1074/jbc.M110.139113;
Atzei P., Gargan S., Curran N., Moynagh P.N.;
"Cactin targets the MHC class III protein IkappaB-like (IkappaBL) and
inhibits NF-kappaB and interferon-regulatory factor signaling
pathways.";
J. Biol. Chem. 285:36804-36817(2010).
[13]
DISEASE.
PubMed=12509789; DOI=10.1086/346067;
Okamoto K., Makino S., Yoshikawa Y., Takaki A., Nagatsuka Y., Ota M.,
Tamiya G., Kimura A., Bahram S., Inoko H.;
"Identification of I kappa BL as the second major histocompatibility
complex-linked susceptibility locus for rheumatoid arthritis.";
Am. J. Hum. Genet. 72:303-312(2003).
-!- FUNCTION: Involved in the regulation of innate immune response.
Acts as negative regulator of Toll-like receptor and interferon-
regulatory factor (IRF) signaling pathways. Contributes to the
negative regulation of transcriptional activation of NF-kappa-B
target genes in response to endogenous proinflammatory stimuli.
{ECO:0000269|PubMed:20829348}.
-!- SUBUNIT: Interacts with CACTIN (via N-terminal domain); the
interaction occurs in a proinflammatory-independent manner.
{ECO:0000269|PubMed:20829348}.
-!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20829348}.
Note=Nuclear localization with a speckled expression pattern in
some cells. Colocalizes with CACTIN in the nucleus.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=3;
Name=1;
IsoId=Q9UBC1-1; Sequence=Displayed;
Name=2;
IsoId=Q9UBC1-2; Sequence=VSP_041075;
Name=3;
IsoId=Q9UBC1-3; Sequence=VSP_046261;
Note=No experimental confirmation available.;
-!- TISSUE SPECIFICITY: Detected in different cell types including
monocytes, T-cells, B-cells and hepatocytes.
-!- DISEASE: Rheumatoid arthritis (RA) [MIM:180300]: An inflammatory
disease with autoimmune features and a complex genetic component.
It primarily affects the joints and is characterized by
inflammatory changes in the synovial membranes and articular
structures, widespread fibrinoid degeneration of the collagen
fibers in mesenchymal tissues, and by atrophy and rarefaction of
bony structures. {ECO:0000305|PubMed:12509789}. Note=Disease
susceptibility is associated with variations affecting the gene
represented in this entry.
-!- SEQUENCE CAUTION:
Sequence=BAG62473.1; Type=Erroneous termination; Positions=255; Note=Translated as Glu.; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; X77909; CAA54867.1; -; mRNA.
EMBL; AB000876; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AB000882; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AF097419; AAD38108.1; -; mRNA.
EMBL; AF097420; AAD38109.1; -; mRNA.
EMBL; AF097421; AAD38110.1; -; mRNA.
EMBL; AF097422; AAD38111.1; -; mRNA.
EMBL; AF097423; AAD38112.1; -; mRNA.
EMBL; AF097424; AAD38113.1; -; mRNA.
EMBL; AF097425; AAD38114.1; -; mRNA.
EMBL; AF097426; AAD38115.1; -; mRNA.
EMBL; AF097427; AAD38116.1; -; mRNA.
EMBL; AF097428; AAD38117.1; -; mRNA.
EMBL; AF097429; AAD38118.1; -; mRNA.
EMBL; Y14768; CAA75072.1; -; Genomic_DNA.
EMBL; AK300818; BAG62473.1; ALT_SEQ; mRNA.
EMBL; BA000025; BAB63398.1; -; Genomic_DNA.
EMBL; AB088115; BAC54951.1; -; Genomic_DNA.
EMBL; AC004181; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AL662847; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AL662801; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BX001040; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AL929587; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BX248516; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CR753892; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CR942185; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BX927320; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH471081; EAX03417.1; -; Genomic_DNA.
EMBL; CH471081; EAX03418.1; -; Genomic_DNA.
EMBL; BC143671; AAI43672.1; -; mRNA.
CCDS; CCDS4700.1; -. [Q9UBC1-1]
CCDS; CCDS47399.1; -. [Q9UBC1-3]
CCDS; CCDS47400.1; -. [Q9UBC1-2]
PIR; S60561; S60561.
RefSeq; NP_001138433.1; NM_001144961.1.
RefSeq; NP_001138434.1; NM_001144962.1.
RefSeq; NP_001138435.1; NM_001144963.1.
RefSeq; NP_004998.3; NM_005007.3.
UniGene; Hs.2764; -.
ProteinModelPortal; Q9UBC1; -.
SMR; Q9UBC1; -.
BioGrid; 110862; 34.
IntAct; Q9UBC1; 12.
STRING; 9606.ENSP00000365318; -.
iPTMnet; Q9UBC1; -.
PhosphoSitePlus; Q9UBC1; -.
BioMuta; NFKBIL1; -.
DMDM; 44888077; -.
EPD; Q9UBC1; -.
MaxQB; Q9UBC1; -.
PaxDb; Q9UBC1; -.
PeptideAtlas; Q9UBC1; -.
PRIDE; Q9UBC1; -.
DNASU; 4795; -.
Ensembl; ENST00000376148; ENSP00000365318; ENSG00000204498.
Ensembl; ENST00000383500; ENSP00000372992; ENSG00000206440. [Q9UBC1-3]
Ensembl; ENST00000400279; ENSP00000383137; ENSG00000206440. [Q9UBC1-2]
Ensembl; ENST00000400285; ENSP00000383142; ENSG00000206440. [Q9UBC1-1]
Ensembl; ENST00000414391; ENSP00000414084; ENSG00000234530. [Q9UBC1-3]
Ensembl; ENST00000419122; ENSP00000394486; ENSG00000234530. [Q9UBC1-1]
Ensembl; ENST00000419623; ENSP00000414206; ENSG00000236346. [Q9UBC1-3]
Ensembl; ENST00000421396; ENSP00000399871; ENSG00000235125. [Q9UBC1-3]
Ensembl; ENST00000424652; ENSP00000395544; ENSG00000236346. [Q9UBC1-1]
Ensembl; ENST00000428467; ENSP00000407809; ENSG00000236346. [Q9UBC1-2]
Ensembl; ENST00000430501; ENSP00000404901; ENSG00000236196. [Q9UBC1-3]
Ensembl; ENST00000430961; ENSP00000411174; ENSG00000235125. [Q9UBC1-2]
Ensembl; ENST00000432160; ENSP00000411611; ENSG00000227565. [Q9UBC1-1]
Ensembl; ENST00000434332; ENSP00000413952; ENSG00000234530. [Q9UBC1-2]
Ensembl; ENST00000442947; ENSP00000396656; ENSG00000235125. [Q9UBC1-1]
Ensembl; ENST00000451911; ENSP00000413643; ENSG00000227565. [Q9UBC1-3]
Ensembl; ENST00000453377; ENSP00000395977; ENSG00000227565. [Q9UBC1-2]
Ensembl; ENST00000455376; ENSP00000408426; ENSG00000236196. [Q9UBC1-1]
Ensembl; ENST00000456607; ENSP00000401830; ENSG00000236196. [Q9UBC1-2]
GeneID; 4795; -.
KEGG; hsa:4795; -.
UCSC; uc003nub.4; human. [Q9UBC1-1]
CTD; 4795; -.
DisGeNET; 4795; -.
EuPathDB; HostDB:ENSG00000204498.10; -.
GeneCards; NFKBIL1; -.
HGNC; HGNC:7800; NFKBIL1.
MalaCards; NFKBIL1; -.
MIM; 180300; phenotype.
MIM; 601022; gene.
neXtProt; NX_Q9UBC1; -.
PharmGKB; PA31604; -.
eggNOG; ENOG410IZ7E; Eukaryota.
eggNOG; ENOG4111NZ2; LUCA.
HOGENOM; HOG000043101; -.
HOVERGEN; HBG048799; -.
InParanoid; Q9UBC1; -.
KO; K09256; -.
OrthoDB; EOG091G0HSG; -.
PhylomeDB; Q9UBC1; -.
TreeFam; TF333242; -.
GeneWiki; NFKBIL1; -.
GenomeRNAi; 4795; -.
PRO; PR:Q9UBC1; -.
Proteomes; UP000005640; Chromosome 6.
Bgee; ENSG00000204498; -.
CleanEx; HS_NFKBIL1; -.
ExpressionAtlas; Q9UBC1; baseline and differential.
Genevisible; Q9UBC1; HS.
GO; GO:0005829; C:cytosol; IEA:Ensembl.
GO; GO:0005634; C:nucleus; IDA:UniProtKB.
GO; GO:0071222; P:cellular response to lipopolysaccharide; IDA:UniProtKB.
GO; GO:0042994; P:cytoplasmic sequestering of transcription factor; TAS:ProtInc.
GO; GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IBA:GO_Central.
GO; GO:0031665; P:negative regulation of lipopolysaccharide-mediated signaling pathway; IDA:UniProtKB.
GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:UniProtKB.
GO; GO:0034122; P:negative regulation of toll-like receptor signaling pathway; IDA:UniProtKB.
GO; GO:0032720; P:negative regulation of tumor necrosis factor production; IMP:UniProtKB.
CDD; cd00204; ANK; 1.
Gene3D; 1.25.40.20; -; 1.
InterPro; IPR020683; Ankyrin_rpt-contain_dom.
InterPro; IPR036770; Ankyrin_rpt-contain_sf.
InterPro; IPR038753; NFKBIL1.
PANTHER; PTHR15263; PTHR15263; 1.
SUPFAM; SSF48403; SSF48403; 1.
PROSITE; PS50297; ANK_REP_REGION; 1.
1: Evidence at protein level;
Alternative splicing; ANK repeat; Complete proteome; Nucleus;
Phosphoprotein; Polymorphism; Reference proteome; Repeat.
CHAIN 1 381 NF-kappa-B inhibitor-like protein 1.
/FTId=PRO_0000067009.
REPEAT 64 93 ANK 1.
REPEAT 97 130 ANK 2.
MOD_RES 150 150 Phosphoserine.
{ECO:0000244|PubMed:18691976}.
VAR_SEQ 1 23 Missing (in isoform 2).
{ECO:0000303|PubMed:14702039}.
/FTId=VSP_041075.
VAR_SEQ 171 185 Missing (in isoform 3).
{ECO:0000303|PubMed:15489334}.
/FTId=VSP_046261.
VARIANT 224 224 C -> R (polymorphism found in the MHC 7.1
haplotype (HLA-A3,B7,DR15) population;
dbSNP:rs3130062).
{ECO:0000269|PubMed:10369924,
ECO:0000269|PubMed:14574404,
ECO:0000269|PubMed:15489334}.
/FTId=VAR_017798.
CONFLICT 48 48 R -> Q (in Ref. 7; BAG62473).
{ECO:0000305}.
CONFLICT 238 239 QQ -> HE (in Ref. 1; CAA54867).
{ECO:0000305}.
SEQUENCE 381 AA; 43204 MW; F466991A92A93F4C CRC64;
MSNPSPQVPE EEASTSVCRP KSSMASTSRR QRRERRFRRY LSAGRLVRAQ ALLQRHPGLD
VDAGQPPPLH RACARHDAPA LCLLLRLGAD PAHQDRHGDT ALHAAARQGP DAYTDFFLPL
LSRCPSAMGI KNKDGETPGQ ILGWGPPWDS AEEEEEDDAS KEREWRQKLQ GELEDEWQEV
MGRFEGDASH ETQEPESFSA WSDRLAREHA QKCQQQQREA EGSCRPPRAE GSSQSWRQQE
EEQRLFRERA RAKEEELRES RARRAQEALG DREPKPTRAG PREEHPRGAG RGSLWRFGDV
PWPCPGGGDP EAMAAALVAR GPPLEEQGAL RRYLRVQQVR WHPDRFLQRF RSQIETWELG
RVMGAVTALS QALNRHAEAL K


Related products :

Catalog number Product name Quantity
EIAAB43424 IkappaBR,I-kappa-B-related protein,Ikbr,Inhibitor of kappa B-related protein,NF-kappa-B inhibitor-like protein 2,Nfkbil2,Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-li
EIAAB43425 Homo sapiens,Human,IkappaBR,I-kappa-B-related protein,IKBR,Inhibitor of kappa B-related protein,NF-kappa-B inhibitor-like protein 2,NFKBIL2,Nuclear factor of kappa light polypeptide gene enhancer in B
EIAAB43423 IkappaBR,I-kappa-B-related protein,Ikbr,Inhibitor of kappa B-related protein,Mouse,Mus musculus,NF-kappa-B inhibitor-like protein 2,Nfkbil2,Nuclear factor of kappa light polypeptide gene enhancer in B
EIAAB43422 Bos taurus,Bovine,IkappaBR,I-kappa-B-related protein,IKBR,Inhibitor of kappa B-related protein,NF-kappa-B inhibitor-like protein 2,NFKBIL2,Nuclear factor of kappa light polypeptide gene enhancer in B-
E1824m ELISA DNA-binding factor KBF1,EBP-1,Mouse,Mus musculus,NF-kappa-B1 p84_NF-kappa-B1 p98,Nfkb1,Nuclear factor NF-kappa-B p105 subunit,Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 96T
U1824m CLIA DNA-binding factor KBF1,EBP-1,Mouse,Mus musculus,NF-kappa-B1 p84_NF-kappa-B1 p98,Nfkb1,Nuclear factor NF-kappa-B p105 subunit,Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 96T
20-372-60032 nuclear factor of kappa light polypeptide gene_enhancer in B-cells inhibitor - Mouse monoclonal anti-human NFKBIA antibody; NF-kappa-BIB; I-kappa-B-beta; IkappaBbeta; IKB-beta; IKB-B; Thyroid receptor 0.1 mg
GWB-BEEF8D nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, Antibody
U1824m CLIA kit DNA-binding factor KBF1,EBP-1,Mouse,Mus musculus,NF-kappa-B1 p84_NF-kappa-B1 p98,Nfkb1,Nuclear factor NF-kappa-B p105 subunit,Nuclear factor of kappa light polypeptide gene enhancer in B-cel 96T
E1824m ELISA kit DNA-binding factor KBF1,EBP-1,Mouse,Mus musculus,NF-kappa-B1 p84_NF-kappa-B1 p98,Nfkb1,Nuclear factor NF-kappa-B p105 subunit,Nuclear factor of kappa light polypeptide gene enhancer in B-ce 96T
201-12-0682 Human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor epsilon,Nfkbie 48T
201-12-0682 Human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor epsilon,Nfkbie 96T
E0681Hu Human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor epsilon,Nfkbie 48T
SL1289Hu human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor epsilon,Nfkbie 96T
YHB2181Hu Human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor epsilon,Nfkbie 96T
201-20-3751 NFKBIB{nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta}rabbit.pAb 0.2ml
E0681Hu Human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor epsilon,Nfkbie 96T
CK-E11212 human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor epsilon,Nfkbie 96T
YHB2181Hu Human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor epsilon,Nfkbie 48T
CK-E97018 human nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor epsilon,Nfkbie
201-20-0048 NFKBIA{nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha}goat.pAb 0.2ml
201-20-3752 NFKBIE{nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon}rabbit.pAb 0.2ml
201-20-6873 NFKBIA{nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha}mouse.mAb 0.2ml
201-20-3750 NFKBIA{nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha}rabbit.pAb 0.2ml
NFRKB NFKBIL1 Gene nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur